An international team of scientists recently reported four SNPs associated with the delayed clearance of Plasmodium falciparum following artemisinin treatment.
Glenmark launched the drug following the revocation of GlaxoSmithKline's patent on Malarone (Atovaquone Proguanil) by the High Court of Britain this week.
Major grants from the European Commission and the German Federal Ministry of Research and Education have been recently awarded for the development of vaccine candidates against pregnancy-associated malaria.
No comments:
Post a Comment